Advicenne Inc.

www.advicenne.com

Advicenne Inc. is the US arm of Advicenne S.A., a Publicly traded French pharmaceutical Company developing Pathbreaking treatments for rare diseases. Our focus in the US is the clinical program for ADV7103. ADV7103 is an investigational drug designed to treat distal renal tubular acidosis (dRTA) in patients of all ages. ADV7103 is also being developed for the treatment of a second indication, cystinuria, an inherited renal tubulopathy.

Read more

Reach decision makers at Advicenne Inc.

Lusha Magic

Free credit every month!

Advicenne Inc. is the US arm of Advicenne S.A., a Publicly traded French pharmaceutical Company developing Pathbreaking treatments for rare diseases. Our focus in the US is the clinical program for ADV7103. ADV7103 is an investigational drug designed to treat distal renal tubular acidosis (dRTA) in patients of all ages. ADV7103 is also being developed for the treatment of a second indication, cystinuria, an inherited renal tubulopathy.

Read more
icon

Country

icon

State

Pennsylvania

icon

Employees

1-10

icon

Estimated Revenue

$1,000,000 to $5,000,000

icon

Social

  • icon

Employees statistics

View all employees

Potential Decision Makers

  • General Manager Usa

    Email ****** @****.com
    Phone (***) ****-****

Technologies

(22)

  • google universal analytics
  • slider revolution
  • wp super cache
  • View all (22)

Reach decision makers at Advicenne Inc.

Free credits every month!

My account

Sign up now to uncover all the contact details